Treat to target in PsA should focus on clinical measures. Response to: 'DAPSA versus cDAPSA: do we need use CRP?' by Gonçalves et al.

van Mens LJJ., van de Sande MGH., van Kuijk AWR., Baeten D., Coates LC.

DOI

10.1136/annrheumdis-2019-215990

Type

Journal article

Journal

Ann rheum dis

Publication Date

22/07/2019

Keywords

arthritis, psoriatic arthritis

Permalink Original publication